Earning Preview: Howmet Aerospace Inc. this quarter’s revenue is expected to increase by 15.40%, and institutional views are broadly bullish

Earnings Agent
04/30

Abstract

Howmet Aerospace Inc. will announce quarterly results on May 7, 2026 Pre-Market; this preview outlines consensus expectations for revenue, profitability, and adjusted EPS alongside segment dynamics and stock-price drivers as investors assess momentum into the first half of the year.

Market Forecast

Consensus for the current quarter points to revenue of 2.24 billion US dollars, an increase of 15.40% year over year, with adjusted EPS projected at 1.11 and EBIT at 610.48 million US dollars, up 42.31% and 34.20% year over year, respectively; margin forecasts were not provided. Within this outlook, the company’s core engineered solutions portfolio remains the largest contributor, while operational leverage and pricing are expected to underpin the year-over-year earnings expansion. The Fastening Systems business is viewed as the most promising near-term growth engine within the mix; based on recent mix proportions, it would represent roughly 0.46 billion US dollars of the quarter’s revenue if the latest distribution holds, within the broader 15.40% year-over-year revenue growth expected for the company.

Last Quarter Review

In the previous quarter, Howmet Aerospace Inc. delivered revenue of 2.17 billion US dollars, up 14.65% year over year, a gross profit margin of 34.87%, GAAP net profit attributable to shareholders of 372.00 million US dollars, a net profit margin of 17.16%, and adjusted EPS of 1.05, up 41.89% year over year. A notable highlight was outperformance versus consensus: revenue exceeded expectations by 42.68 million US dollars and adjusted EPS topped projections by 0.08. Main business contributions remained balanced across the portfolio, with Engineered Products and Solutions accounting for approximately 52.35% of revenue, implying around 1.13 billion US dollars for the quarter, and Fastening Systems contributing about 458.45 million US dollars; the company-level top line advanced 14.65% year over year.

Current Quarter Outlook

Main business: Engineered Products and Solutions

The core engineered solutions portfolio continues to anchor the company’s top line and margins. Consensus for the current quarter implies 2.24 billion US dollars of revenue, up 15.40% year over year, and the current mix suggests this portfolio would again contribute just over half of total sales. The step-up in adjusted EPS to 1.11, implying 42.31% year-over-year growth, aligns with continued positive mix effects and pricing carryover, alongside volume leverage on fixed costs. Management’s recent execution has translated into a 34.87% gross margin and a 17.16% net margin last quarter; while explicit margin forecasts for this quarter are not available, investors will look for comparable or incremental improvement driven by disciplined pricing, favorable product mix, and ongoing productivity. Order intake and backlog commentary typically act as readthroughs for future revenue visibility; sustaining or improving the book-to-bill within the core engineered solutions suite would reinforce the durability behind the double-digit revenue growth embedded in the current-quarter consensus.

Most promising business: Fastening Systems

Fastening Systems appears positioned to outgrow the corporate average, with consensus dynamics implying that strong component demand and ongoing mix improvements will support above-trend revenue progress and strong operating leverage. Using the company’s most recent revenue mix as a guide, the Fastening Systems business would represent around 458.45 million US dollars this quarter if proportions are stable, within the context of a 15.40% year-over-year company-wide revenue increase. Investors will watch for commentary on fill rates, any incremental price actions, and the degree of drop-through from volume to profits, as these have historically driven margin expansion for this product set. Given the sensitivity of this business to order patterns and production schedules at major customers, management’s updates on order activity and delivery cadence can meaningfully influence sentiment; continued momentum would help validate the 34.20% year-over-year EBIT growth implicit in the current-quarter forecast.

Key share-price swing factors this quarter

Guidance tone and the qualitative outlook into the second half remain the key swing variables for the stock reaction. With consensus modeling revenue up 15.40% year over year and adjusted EPS up 42.31%, any shift in full-year language—whether on volume expectations, pricing sustainability, or cost normalization—could move the shares. Free cash flow and working-capital cadence are secondary but important levers; while the company historically sees seasonal working-capital builds early in the year, investors will evaluate whether cash conversion tracks management’s typical framework and how inventory balances evolve versus sales. Margin commentary will be closely read; last quarter’s 34.87% gross margin and 17.16% net margin set a constructive baseline, and any evidence of manufacturing productivity, cost absorption improvements, or favorable product mix could support further operating margin progress. Finally, portfolio updates could influence medium-term modeling: the acquisition of Consolidated Aerospace Manufacturing closed on April 6, 2026 and will not contribute to the period being reported, yet investors will look for integration updates, synergy goals, and the expected revenue and margin profile for subsequent quarters, as that context can shape expectations beyond the current print.

Other operational considerations

Order intake and backlog trends are shorthand indicators for forward planning and revenue stability. Against consensus that calls for EBIT of 610.48 million US dollars, investors will be attentive to the relationship between orders and shipments in the core product families and whether order momentum is keeping pace with sales expansion. Pricing discipline is another focal point; commentary that confirms retention of prior price actions and incremental realization on new and renewal contracts would underpin confidence in profitability resilience. On costs, management’s transparency around material inputs and conversion costs is helpful for triangulating gross margin trajectory; signals of improved yields, throughput gains, or reduced scrap would support sustained margin advancement. Headcount and capacity plans can also affect both near-term productivity and the cost outlook; incremental capacity adds are judged against the visibility of demand to ensure efficient asset utilization. Finally, any qualitative comments regarding logistics and supplier readiness, where relevant, could act as a catalyst for sentiment if they frame either operational tailwinds or bottlenecks to watch.

Financial bridge and sensitivity

The implied bridge from last quarter’s 2.17 billion US dollars of revenue and 1.05 adjusted EPS to this quarter’s 2.24 billion US dollars and 1.11 adjusted EPS suggests a combination of mid-teens top-line growth and strong incremental margins. In practical terms, this points to pricing and volume leverage delivering more than proportionate growth in operating profit, consistent with the 34.20% year-over-year EBIT expansion expectation. Investors often triangulate incremental EBIT margins from sales growth; if revenue lands near the 2.24 billion US dollars mark, observed conversion rates will inform whether the current trajectory of earnings power is tracking ahead of, in line with, or behind modeled run-rates. On the bottom line, the comparison base is favorable, as last quarter’s adjusted EPS growth of 41.89% year over year establishes momentum into the current period; any upside surprise in revenue mix, cost efficiencies, or price realization could skew EPS above the 1.11 consensus. Conversely, a miss on volumes or a shift in product mix toward lower-margin categories would likely compress the anticipated drop-through, tempering the earnings outperformance scenario.

What investors will listen for on the call

- Commentary on orders and delivery schedules that supports visibility around the current double-digit revenue growth profile. - The degree to which pricing actions continue to offset cost inflation and how much pricing tailwind remains for the balance of the year. - Updates on manufacturing productivity, including throughput, yields, and any investments that expand capacity or reduce conversion cost. - Free cash flow cadence and capital allocation priorities, including share repurchases, capital expenditures, and integration spending for the newly acquired business (with the reminder that its impact begins after the period being reported). - The qualitative framing for the next quarter, given the imminent inclusion of the acquired operations, and whether that changes the expected revenue and margin trajectory for the rest of the year.

Analyst Opinions

Across the collected commentary between January and April, the balance of opinions is decisively positive: bullish views account for 100% of the tracked ratings and target adjustments, while bearish calls were not observed in the period. Several well-followed institutions reiterated constructive stances alongside higher or reaffirmed price targets. Analysts at Bernstein, led by Douglas Harned, maintained a Buy rating with a price target of 280 US dollars, citing ongoing execution and confidence in earnings growth. Truist Financial’s Michael Ciarmoli likewise reiterated a Buy with a 280 US dollars target, reflecting expectations for continued top-line expansion and profit improvement. RBC Capital’s Kenneth Herbert remained positive with a Buy rating and a 255 US dollars target, while TD Cowen’s Gautam Khanna also maintained Buy at 240 US dollars. Additional updates noted in late March and April highlighted an average rating of Buy/Overweight with targets broadly clustered in the 265–280 US dollars range, including adjustments from Argus (to 280 US dollars), Citigroup (to 271 US dollars, Buy), BNP Paribas (Outperform, 265 US dollars), and Wolfe (Outperform, 278 US dollars).

The core of the bullish majority is the expectation that revenue growth can sustain at a mid-teens pace in the near term while margins continue to benefit from pricing actions, product mix, and operating leverage. The 15.40% year-over-year revenue increase embedded in current-quarter forecasts, coupled with 34.20% year-over-year EBIT growth and a 42.31% rise in adjusted EPS, aligns with the pattern of upside seen in the prior quarter, where revenue topped consensus by 42.68 million US dollars and adjusted EPS exceeded estimates by 0.08. In their view, the company’s mix of engineered solutions and high-value components positions it to translate incremental revenue into disproportionate profit gains. The analysts also emphasize the importance of consistent book-to-bill dynamics and steady order intake, as these underpin the visibility implied by the consensus trajectory.

Many of the Buy-rated notes reference the potential for further margin expansion if cost normalization and productivity initiatives continue to compound the effects of pricing and mix. With last quarter’s gross margin at 34.87% and net margin at 17.16%, the setup for the current quarter appears supportive of another period of healthy profitability, even though formal margin guidance has not been provided. Analysts are also attentive to the near-term catalysts in the operating playbook: confirmation that pricing remains sticky, that mix skews toward higher-value product lines, and that conversion costs trend down as throughput improves. In addition, while the newly acquired operations will not affect the period being reported, discussions around integration timeline and synergy capture can influence medium-term models and, by extension, target prices.

The majority view interprets the recent string of positive target recalibrations in March and April as validation of the earnings power implied by the double-digit growth forecasts. The expectation is that the upcoming report will show that the company is continuing to close the gap between revenue growth and operating income growth, with conversion rates improving on better mix and pricing carryover. On balance, the collected analyst opinions suggest investors will use the May 7, 2026 Pre-Market results to confirm that the current-quarter estimates—2.24 billion US dollars of revenue, 610.48 million US dollars of EBIT, and 1.11 adjusted EPS—are attainable, and to assess whether the cadence of bookings and operational execution can sustain momentum into the subsequent quarter when the recently acquired assets begin to contribute. Should the company deliver along these lines, the bullish case argues for continued support for valuation through a combination of earnings growth and reinforced visibility into the remainder of the year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10